Invigor Medical vs Nolu
Two GLP-1 desks, one scoreboard. We put Invigor Medical and Nolu head-to-head on the published Brief Score — the same six factors, scored the same way.
Invigor Medical
The verdict
Invigor Medical takes this head-to-head.
Invigor Medical scores 88 to 79 on our six-factor Brief Score — An established telehealth pharmacy with a broad metabolic and hormone catalog and a steady price line.
That doesn't make Nolu a bad call — it's best for readers who want one bundled per-order price (consult, medication, shipping) and will budget for 13 billing cycles a year rather than 12. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Invigor Medical | Nolu | |
|---|---|---|
| Brief Score | 88/100 (B+) | 79/100 (C) |
| Semaglutide | $199/mo | $249/mo injectable · $279/mo oral (billed per 4 weeks) |
| Tirzepatide | $339/mo | $339/mo injectable (billed per 4 weeks) |
| Coverage | Not disclosed | All 50 states + DC |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Yes |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
Invigor Medical: Long-running operator; mid-market pricing unchanged this cycle.
Nolu: First reading — all-in per-order pricing, but billed every 4 weeks rather than by the calendar month.
● Not sold on either?
CoreAge Rx tops the whole board at 94/100.
The steadiest desk on the board: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.